Autoimmune Diseases
Welcome,         Profile    Billing    Logout  
 293 Companies   491 Products   491 Products   198 Mechanisms of Action   26 Trials   7806 News 


«12...1516171819202122232425...156157»
  • ||||||||||  Enrollment change:  Power Over Pain (POP) Study (clinicaltrials.gov) -  Apr 26, 2017   
    P=N/A,  N=177, Active, not recruiting, 
    N=144 --> 177
  • ||||||||||  Trial completion:  TC-A Registration Study (clinicaltrials.gov) -  Apr 26, 2017   
    P=N/A,  N=162, Completed, 
    Active, not recruiting --> Completed | N=40 --> 26 Active, not recruiting --> Completed
  • ||||||||||  Trial initiation date:  Excia T Cementless EBRA Study (clinicaltrials.gov) -  Apr 26, 2017   
    P=N/A,  N=100, Not yet recruiting, 
    Active, not recruiting --> Completed Initiation date: Dec 2016 --> Aug 2017
  • ||||||||||  Trial primary completion date:  Sequencing T-cells in Type I Diabetes Mellitus (clinicaltrials.gov) -  Apr 26, 2017   
    P=N/A,  N=40, Active, not recruiting, 
    Initiation date: Dec 2016 --> Aug 2017 Trial primary completion date: Apr 2017 --> Sep 2017
  • ||||||||||  Trial primary completion date:  Insulin-based Strategies to Prevent Hypoglycemia During Exercise (clinicaltrials.gov) -  Apr 26, 2017   
    P=N/A,  N=23, Recruiting, 
    Trial primary completion date: Jul 2014 --> Feb 2017 Trial primary completion date: Mar 2017 --> Jun 2017
  • ||||||||||  Humalog pen (insulin lispro) / Eli Lilly
    Trial completion:  Insulin Bolus Required for High Fat Foods in Type 1 Diabetes (clinicaltrials.gov) -  Apr 26, 2017   
    P=N/A,  N=10, Completed, 
    Trial primary completion date: Mar 2017 --> Jun 2017 Enrolling by invitation --> Completed
  • ||||||||||  donepezil / Generic mfg.
    Enrollment change:  Improving Memory in Patients With Multiple Sclerosis (clinicaltrials.gov) -  Apr 25, 2017   
    P3,  N=0, Withdrawn, 
    Recruiting --> Completed N=60 --> 0
  • ||||||||||  Trial completion, Phase classification, Enrollment change, Trial primary completion date:  Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis (clinicaltrials.gov) -  Apr 25, 2017   
    P=N/A,  N=70, Completed, 
    N=60 --> 0 Enrolling by invitation --> Completed | Phase classification: P2/3 --> PN/A | N=184 --> 70 | Trial primary completion date: Jan 2014 --> Sep 2015
  • ||||||||||  Orencia (abatacept) / BMS
    Trial completion, P4 data:  Post-marketing Study Assessing the Long-Term Safety of Abatacept (clinicaltrials.gov) -  Apr 25, 2017   
    P=N/A,  N=100000, Completed, 
    Enrolling by invitation --> Completed | Phase classification: P2/3 --> PN/A | N=184 --> 70 | Trial primary completion date: Jan 2014 --> Sep 2015 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial initiation date, Trial primary completion date:  Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment (clinicaltrials.gov) -  Apr 24, 2017   
    P1,  N=1, Completed, 
    Active, not recruiting --> Completed Not yet recruiting --> Completed | N=15 --> 1 | Initiation date: Jul 2017 --> Jul 2008 | Trial primary completion date: Dec 2020 --> Apr 2017
  • ||||||||||  tibulizumab (ZB-106) / Zura Bio
    Trial primary completion date:  A Study of LY3090106 in Participants With Sj (clinicaltrials.gov) -  Apr 24, 2017   
    P1,  N=32, Recruiting, 
    N=48 --> 21 Trial primary completion date: Sep 2017 --> Mar 2018
  • ||||||||||  Remicade (infliximab) / J&J
    Phase classification:  HARIR: Tracking Biologics Along the Silk Road (clinicaltrials.gov) -  Apr 21, 2017   
    P=N/A,  N=338, Recruiting, 
    Active, not recruiting --> Completed Phase classification: P4 --> P=N/A
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes (clinicaltrials.gov) -  Apr 17, 2017   
    P=N/A,  N=7, Completed, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2016 --> Sep 2017 Recruiting --> Completed | N=52 --> 7 | Trial primary completion date: Sep 2015 --> Dec 2014
  • ||||||||||  Sotyktu (deucravacitinib) / BMS
    Trial completion:  Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin (clinicaltrials.gov) -  Apr 17, 2017   
    P1,  N=20, Completed, 
    Recruiting --> Completed | N=52 --> 7 | Trial primary completion date: Sep 2015 --> Dec 2014 Recruiting --> Completed
  • ||||||||||  Trial completion:  LADA: Genetics of Latent Autoimmune Diabetes in Adults (clinicaltrials.gov) -  Apr 13, 2017   
    P=N/A,  N=205, Completed, 
    Recruiting --> Active, not recruiting | N=70 --> 50 Active, not recruiting --> Completed
  • ||||||||||  Kenketsu Glovenin-I (normal human immunoglobulin IV) / Takeda
    Trial completion, Trial initiation date:  Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barr (clinicaltrials.gov) -  Apr 11, 2017   
    P3,  N=22, Completed, 
    Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Aug 2015 Recruiting --> Completed | Initiation date: Apr 2014 --> Oct 2014
  • ||||||||||  Phase classification, Trial primary completion date, Immunomodulating:  Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple Sclerosis (clinicaltrials.gov) -  Apr 11, 2017   
    P1,  N=16, Active, not recruiting, 
    Recruiting --> Completed | Initiation date: Apr 2014 --> Oct 2014 Phase classification: P=N/A --> P1 | Trial primary completion date: Mar 2017 --> Apr 2016